Applications, Limitations, and Clinical Impact
A deep dive into dried urine testing for hormones in perimenopause and menopause — how it compares to serum and saliva, and how urinary metabolites can guide and fine-tune hormone replacement therapy.
Doors open in
Takes about 30 seconds · No card required
Wednesday, September 16 · 7:00–9:00 PM ET
2 hours, with time for questions
Part of the Hormone Virtual Summit
Learning objectives
By the end of this session, participants will be able to:
Compare urinary hormone metabolite testing with serum and saliva
Review how to efficiently and effectively read a DUTCH report
Review perimenopause/menopause physiology and symptoms
Review FDA approved hormone replacement therapies for menopausal patients
Review case vignettes that illustrate how to use DUTCH testing to monitor and optimize hormone therapy in both menopausal and perimenopausal patients
Understand the difference between free cortisol and cortisol metabolites for a complete picture of HPA axis function and treatment
Your speaker
Clinical Consultant, Precision Analytical · Sparrow Medicine, Bozeman, MT
Dr. McKenzie Mescon received her doctorate in naturopathic medicine from the National University of Health Sciences in 2016. Following graduation, she completed a residency in Primary Care and General Practice. Dr. Mescon is a second-generation Institute for Functional Medicine Certified Practitioner, having completed her training with the IFM in 2023.
In addition to working with Precision Analytical as a Clinical Consultant, Dr. Mescon maintains a clinical practice where she focuses on women’s health including fertility, perimenopause and HRT, as well as fatigue and thyroid disorders. Her practice, Sparrow Medicine, is located in Bozeman, Montana.
About this session
In this webinar, we take a deep dive into dried urine testing for hormones in the context of perimenopause and menopause, with a focus on its utility in hormone replacement therapy. We’ll discuss the differences between, and considerations for testing hormones in the serum, saliva and dried urine before diving into case-based discussions of estrogen, progesterone, androgens, and cortisol.
We’ll cover case vignettes that examine how to use urinary hormone metabolite testing to guide and fine-tune hormone replacement therapy in both menopausal and perimenopausal patients. In addition, we’ll examine cases that go beyond salivary cortisol, using urinary cortisol metabolites to obtain a complete picture for the optimal treatment of the HPA axis and metabolism.
With time for questions, you’ll leave this webinar understanding the meaningful impact dried urine testing has in clinical assessment, and with the confidence to use it efficiently in your clinical practice.
Wednesday, September 16, 2026 · 7:00–9:00 PM ET